IP Library Granted Patent US 7,488,587
Granted Patent B2
US 7,488,587 · App. 10/175,559 · Granted Feb 10, 2009

Histone deacetylase and methods of use thereof

Assignee: The J. David Gladstone Institutes
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,488,587
App. No.
10/175,559
Granted
Feb 10, 2009
Kind
B2
Abstract

The present invention provides nucleic acid molecules that encode histone deacetylase, as well as recombinant vectors and host cells that include the subject nucleic acid molecules. Also provided are histone deacetylase polypeptide compositions. The histone deacteylase nucleic acid molecules are useful in a variety of diagnostic and therapeutic applications, which are also provided.

Claims (14)

1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding an enzymatically active histone deacetylase-7 (HDAC-7) polypeptide, wherein said HDAC-7-encoding nucleotide sequence has at least 95% nucleotide sequence identity to the coding region of SEQ ID NO:1, wherein the encoded HDAC-7 polypeptide comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2.

2. An expression cassette comprising a transcriptional initiation region functional in an expression host, a nucleic acid molecule encoding an enzymatically active histone deacetylase-7 (HDAC-7) polypeptide, wherein said HDAC-7-encoding nucleotide sequence has at least 95% nucleotide sequence identity to the coding region of SEQ ID NO:1, wherein the encoded HDAC-7 polypeptide comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, said nucleic acid molecule under the transcriptional regulation of said transcriptional initiation region, and a transcriptional termination region functional in said expression host.

3. A genetically modified cell comprising an expression cassette according to claim 2 as part of an extrachromosomal element or integrated into the genome of a host cell as a result of introduction of said expression cassette into said host cell.

4. A method of producing a histone deacetylase, said method comprising:

growing a cell according to claim 3 , whereby said histone deacetylase is expressed; and

isolating said histone deacetylase substantially free of other proteins.

5. The nucleic acid molecule of claim 1 , wherein said HDAC-7-encoding nucleotide sequence has at least 98% nucleotide sequence identity to the coding region of SEQ ID NO:1.

6. A recombinant nucleic acid comprising a nucleotide sequence encoding an enzymatically active histone deacetylase-7 (HDAC-7) polypeptide that lacks amino terminal amino acid residues 1-437 of SEQ ID NO:2, wherein the nucleotide sequence encodes amino acids 438 to 912 of the amino acid sequence set forth in SEQ ID NO:2.

7. A recombinant nucleic acid comprising a nucleotide sequence encoding a histone deacetylase-7 (HDAC-7) polypeptide that lacks amino acids 438 to 912 of SEQ ID NO:2, wherein the nucleotide sequence encodes amino acids 1 to 437 of the amino acid sequence set forth in SEQ ID NO:2, and wherein said HDAC-7 polypeptide functions as a dominant negative mutant.

8. The expression cassette of claim 2 , wherein said HDAC-7-encoding nucleotide sequence has at least 98% nucleotide sequence identity to the coding region of SEQ ID NO:1.

9. An expression cassette comprising a transcriptional initiation region functional in an expression host, a nucleic acid according to claim 7 , wherein said nucleic acid is under the transcriptional regulation of said transcriptional initiation region, and a transcriptional termination region functional in said expression host.

10. An expression cassette comprising a transcriptional initiation region functional in an expression host; a nucleic acid according to claim 6 , wherein said nucleic acid is under the transcriptional regulation of said transcriptional initiation region; and a transcriptional termination region functional in said expression host.

11. A genetically modified cell comprising an expression cassette according to claim 10 as part of an extrachromosomal element or integrated into the genome of a host cell as a result of introduction of said expression cassette into said host cell.

12. A genetically modified cell comprising an expression cassette according to claim 9 as part of an extrachromosomal element or integrated into the genome of a host cell as a result of introduction of said expression cassette into said host cell.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jul 16, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024699/0285 →
CONFIRMATORY LICENSE Recorded Apr 16, 2008
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020812/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2006
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: J. DAVID GLADSTONE INSTITUTES, THE
Reel/Frame 017595/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2002
From: VERDIN, ERIC; FISCHLE, WOLFGANG; DEQUIEDT, FRANCK O.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 013364/0957 →
Continuity (2)
Provisional Application 6029922800 · Jun 19, 2001
Related Publication 20030143712A1 · Jul 31, 2003